Is Compounded Semaglutide or Tirzepatide Legit? How to Tell

If you are close to starting compounded semaglutide, or compounded tirzepatide, but a quiet voice keeps asking whether it is the real thing or some kind of scam, that hesitation is healthy. The short answer is that both can be completely legitimate, but only when a licensed provider prescribes the medication and a US-based, state-licensed pharmacy prepares it. The source is what separates a legitimate option from a risky one, so the smartest thing you can do is learn how to tell them apart. Everything on this page applies to both molecules, and we cover the tirzepatide-specific details in their own section below.

The short answer

Compounded semaglutide can be legitimate, and so can compounded tirzepatide. Each is a real medication that licensed pharmacies prepare for individual patients when a provider has written a prescription. Neither is, by itself, a scam.

There are three things to hold in your mind at the same time, and they are all true.

First, compounded semaglutide and compounded tirzepatide are not FDA-approved. The FDA has not reviewed the specific product you receive the way it reviewed the brand-name versions of these medications. That is a structural fact, not an opinion, and it should factor into your decision.

Second, the legal framework is evolving. Compounding is permitted under specific federal and state pharmacy laws, and the basis for compounding semaglutide and tirzepatide is tied to the FDA drug shortage list, which has been changing. We cover this in detail below.

Third, quality varies enormously from one source to the next. A pharmacy that holds a verifiable state license, tests every batch, and requires a prescription is operating in a different world than a website that ships from overseas with no oversight. Because the regulators do not pre-screen the specific product for you, the burden of vetting the source falls partly on you. The rest of this page gives you a way to do that with confidence.

What makes compounded semaglutide or tirzepatide legitimate

Legitimacy is not a vibe. It is a short list of concrete things you can check, and the checklist is the same whether the medication is compounded semaglutide or compounded tirzepatide. When all of them are present, you are most likely looking at a responsible operation. When several are missing, step back.

A prescription is required. A legitimate source will not sell you semaglutide or tirzepatide without a prescription from a licensed provider who has reviewed your health history. Every prescription requires an independent, licensed provider, and not all patients qualify. If a website lets you add either medication to a cart and check out with no medical review, that alone tells you it is not legitimate.

The pharmacy is a US-based, state-licensed 503A or 503B pharmacy. A 503A pharmacy compounds for individual patients with a patient-specific prescription. A 503B outsourcing facility is registered with the FDA and follows additional manufacturing standards. Either can be legitimate. What matters is that the pharmacy is licensed in the US and you can verify it. If you want to understand the distinction, our guide on 503A versus 503B pharmacies walks through it.

The pharmacy holds PCAB accreditation or comparable quality standards. Accreditation from the Pharmacy Compounding Accreditation Board is voluntary, so its absence is not automatically disqualifying, but its presence is a meaningful signal that a pharmacy meets standards beyond the regulatory minimum.

A certificate of analysis is available. A responsible pharmacy can provide a certificate of analysis, or COA, showing that an independent lab tested the batch for potency and purity. You should be able to request one for the medication you receive.

There is ongoing provider oversight, including labs. Legitimacy is not just about the first prescription. A trustworthy program includes a provider who monitors your response, orders lab work when appropriate, and adjusts your plan over time. Medication that arrives with no follow-up and no one tracking how you are doing is a sign the medical piece is missing.

For a deeper look at how these factors affect safety specifically, see our page on whether compounded semaglutide is safe.

Red flags of an illegitimate source

It is often easier to spot what is wrong than to confirm everything that is right. Some warning signs are serious enough that any one of them should stop you. The contrast below lays out what a legitimate provider looks like next to the patterns the FDA has repeatedly flagged in its enforcement actions.

A few of these deserve a closer look. “Research only” or “not for human consumption” labeling paired with dosing instructions is a tactic used to evade regulation, and it is one of the clearest signs you are not dealing with a pharmacy. Overseas or unverified sourcing removes the quality guardrails that licensed US pharmacies operate under. And pricing that is dramatically lower than everything else is often a clue that the product is not what it claims to be, because real pharmacy-grade preparation and testing cost money.

Is it legal?

This is the question that trips people up, and it deserves an honest answer rather than a reassuring slogan. Neither compounded semaglutide nor compounded tirzepatide is simply “legal” or “illegal.” Both sit inside a framework that is genuinely evolving.

Here is the plain-language version. Federal law allows licensed pharmacies to compound copies of a commercially available drug in limited circumstances, and one of the main circumstances is when the drug is on the FDA drug shortage list. For much of the period when GLP-1 medications were hard to get, both semaglutide and tirzepatide were on that list, which gave compounding pharmacies a clear basis to prepare them.

That situation changed. The FDA declared the tirzepatide shortage resolved in late 2024 and removed semaglutide from the shortage list in early 2025 as supply of the brand-name products improved. When a drug comes off the shortage list, the legal footing for compounding it shifts, and the rules around what 503A and 503B pharmacies may do become more specific. Patient-specific compounding by 503A pharmacies continues in some circumstances, but the framework is more constrained than it was during the shortage, and it continues to be shaped by FDA guidance and state pharmacy law.

What this means for you is straightforward. A legitimate provider follows the current rules and is transparent about them. Anyone who tells you compounded semaglutide or tirzepatide is “100% legal, no questions” is overselling a more complicated reality. For a fuller picture of how the rules shifted after supply improved, see our page on compounded GLP-1 medications after the shortage.

Is compounded tirzepatide legit?

Yes, compounded tirzepatide can be legitimate under the same conditions as compounded semaglutide. The legal framework is identical. Both medications are compounded under sections 503A and 503B of federal pharmacy compounding law, both require a prescription from a licensed provider, and both must come from a US-based, state-licensed pharmacy to be worth considering. Every item on the legitimacy checklist above, from the verifiable pharmacy license to the certificate of analysis to ongoing provider oversight, applies to tirzepatide exactly as it does to semaglutide.

The main difference between the two molecules is the shortage-list history. The FDA declared the tirzepatide shortage resolved in late 2024, several months before it removed semaglutide from the shortage list in early 2025. That means the post-shortage rules have applied to compounded tirzepatide for longer, and the FDA has been more active in discouraging large-batch 503B compounding of tirzepatide. Patient-specific compounding through 503A pharmacies continues in some circumstances, but availability is not guaranteed and can change as FDA guidance and state pharmacy law evolve.

One practical note on spotting bad actors. Legitimate compounded tirzepatide is an injectable medication. A seller offering tirzepatide with no prescription, or marketing it as a “research” peptide, should be treated exactly like the red flags described above.

If you are weighing tirzepatide specifically, our overview of compounded tirzepatide explains what it is and how it works, and our guide on how to get compounded tirzepatide walks through the process step by step.

How to verify a provider yourself

You do not have to take anyone’s word for it. With a few minutes and a couple of questions, you can verify the most important things on your own.

Look up the pharmacy license. Ask which compounding pharmacy will prepare your medication and for its state license number. Then search your state pharmacy board website, which maintains a public license lookup. A legitimate pharmacy will have an active, verifiable license. If a seller will not name the pharmacy, that is your answer.

Check for PCAB accreditation. You can confirm whether a pharmacy holds accreditation from the Pharmacy Compounding Accreditation Board. It is not mandatory, so its absence alone is not a dealbreaker, but it is a useful additional signal of quality.

Ask for the certificate of analysis. Request the COA for the batch your medication comes from. A responsible pharmacy can provide documentation of independent testing for potency and purity. Vagueness or refusal here is a meaningful red flag.

Confirm there is a real prescription and provider review. Make sure a licensed provider reviews your health history before anything is prescribed. This is both a legal requirement and a basic safety feature. A genuine program will tell you exactly how the provider review works.

If you want a complete checklist for evaluating a pharmacy, our guide on how to choose a safe compounding pharmacy goes step by step.

How Transformation Health approaches this

We built our program around exactly the standards described above, because the source is where legitimacy lives.

When you work with Transformation Health, an independent, licensed provider reviews your health history, your current medications, and your goals, and determines whether semaglutide or tirzepatide is clinically appropriate for you. Transformation Health does not prescribe. The clinical decision rests with the provider, and not all patients qualify.

If a prescription is appropriate, it goes to a US-based, state-licensed compounding pharmacy that we have vetted. Our pharmacy partners hold active state licenses, source active ingredients from FDA-registered US suppliers, and provide a certificate of analysis for their batches. Your provider continues to monitor your response over time and orders lab work as part of the program.

Pricing is all-inclusive, which means your monthly fee covers your medication, lab work, and medical weight loss coaching, with no hidden fees, and you can cancel anytime. To understand the full category and how compounded options are prepared, you can start with our compounded GLP-1 medications overview.

Residents of AR, DC, DE, MS, NM, RI, and WV are required by state law to complete a live video consultation with a provider before a prescription can be written.

Important disclosures

Compounded semaglutide is not an FDA-approved product. It is prepared by US-based, state-licensed compounding pharmacies and has not been independently evaluated by the FDA for safety, efficacy, or quality. It is not the same as brand-name semaglutide. Whether it is appropriate for you is a decision you make together with a licensed provider based on your health history.

The same disclosures apply to compounded tirzepatide. It is not an FDA-approved product, it is prepared by US-based, state-licensed compounding pharmacies, it has not been independently evaluated by the FDA for safety, efficacy, or quality, and it is available in injectable form only.

The legal and regulatory framework for compounded semaglutide and compounded tirzepatide is evolving and depends on FDA drug shortage-list status as well as applicable state and federal pharmacy compounding laws, which may change. Availability of these compounded medications may change as those rules change. References to FDA guidance and the FDA drug shortage list here are general and are intended to help you understand the landscape, not to serve as legal advice.

All prescriptions require evaluation by an independent, licensed healthcare provider. Not all patients will qualify. Results vary by individual. If you are evaluating any provider or pharmacy, verify the pharmacy license, request a certificate of analysis, and confirm that a prescription and provider review are part of the process before you start.